Highbridge Capital Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Highbridge Capital Management’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,908,157	Closed	-$18.9M	–	724
2021 Q4	$18.9M	Buy	1,908,157 +115,776	+6%	+$1.15M	0.45%	59
2021 Q3	$17.7M	Buy	1,792,381 +705,357	+65%	+$6.91M	0.5%	68
2021 Q2	$10.7M	Buy	1,087,024 +464,694	+75%	+$4.53M	0.32%	102
2021 Q1	$6.03M	Buy	+622,330	New	+$6.11M	0.26%	93

Other funds holding GRNA

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oxbow Capital Management (HK) Hong Kong $371M AUM 383.45% 1-Year Est. Return